The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
A bismuth salt of salicylic acid. Little absorbed from the
gastrointestinal tract, bismuth subsalicylate exerts a local effect on
the gastric mucosa, coating it and protecting it from the corrosive
effects of acid and pepsin. This agent also has local antimicrobial